135 related articles for article (PubMed ID: 6179469)
1. Anti-herpesvirus activity of adenine arabinoside analogues in tissue culture and a genital infection of mice and guinea pigs.
Richards JT; Kern ER; Overall JC; Glasgow LA
Antiviral Res; 1982 May; 2(1-2):27-39. PubMed ID: 6179469
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of 5-methoxymethyl-2'-deoxyuridine in combination with arabinosyladenine for the treatment of primary herpes simplex genital infection of mice and guinea pigs.
Ayisi NK; Gupta SV; Babiuk LA
Antiviral Res; 1986 Jan; 6(1):33-47. PubMed ID: 3008644
[TBL] [Abstract][Full Text] [Related]
3. Failure of 2-deoxy-D-glucose in the treatment of experimental cutaneous and genital infections due to herpes simplex virus.
Kern ER; Glasgow LA; Klein RJ; Friedman-Kien AE
J Infect Dis; 1982 Aug; 146(2):159-66. PubMed ID: 6286785
[TBL] [Abstract][Full Text] [Related]
4. Acyclovir treatment of experimental genital herpes simplex virus infections.
Kern ER
Am J Med; 1982 Jul; 73(1A):100-8. PubMed ID: 6285699
[TBL] [Abstract][Full Text] [Related]
5. Antiherpesvirus activity in human sera and urines after administration of adenine arabinoside: in vitro and in vivo synergy of adenine arabinoside and arabinosylhypoxanthine in combination.
Champney KJ; Lauter CB; Bailey EJ; Lerner AM
J Clin Invest; 1978 Dec; 62(6):1142-53. PubMed ID: 219024
[TBL] [Abstract][Full Text] [Related]
6. A comparison of phosphonoacetic acid and phosphonoformic acid activity in genital herpes simplex virus type 1 and type 2 infections of mice.
Kern ER; Richards JT; Overall JC; Glasgow LA
Antiviral Res; 1981 Nov; 1(4):225-35. PubMed ID: 6280607
[TBL] [Abstract][Full Text] [Related]
7. Acyclovir treatment of experimental genital herpes simplex virus infections. I. Topical therapy of type 2 and type 1 infections of mice.
Kern ER; Richards JT; Overall JC; Glasgow LA
Antiviral Res; 1983 Nov; 3(4):253-67. PubMed ID: 6320718
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of HPMPC therapy for primary and recurrent genital herpes in mice and guinea pigs.
Bravo FJ; Stanberry LR; Kier AB; Vogt PE; Kern ER
Antiviral Res; 1993 May; 21(1):59-72. PubMed ID: 8391249
[TBL] [Abstract][Full Text] [Related]
9. Alteration of mortality and pathogenesis of three experimental Herpesvirus hominis infections of mice with adenine arabinoside 5'-monophosphate, adenine arabinoside, and phosphonoacetic acid.
Kern ER; Richards JT; Overall JC; Glasgow LA
Antimicrob Agents Chemother; 1978 Jan; 13(1):53-60. PubMed ID: 204250
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of prodrugs of 9-beta-D-arabinofuranosyladenine for therapeutic efficacy in the topical treatment of genital herpesvirus infections in guinea pigs.
Shannon WM; Arnett G; Baker DC; Kumar SD; Higuchi WI
Antimicrob Agents Chemother; 1983 Nov; 24(5):706-12. PubMed ID: 6686429
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the antiviral effects of 5-methoxymethyldeoxyuridine-5'-monophosphate with adenine arabinoside-5'-monophosphate.
Ayisi NK; Meldrum JB; Stuart AL; Gupta VS
Antiviral Res; 1983 Sep; 3(3):161-74. PubMed ID: 6197027
[TBL] [Abstract][Full Text] [Related]
12. Antiviral activity in the rabbit cornea of adenine arabinoside, Ara-A 5' monophosphate, and hypoxanthine arabinoside; and interactions with adenosine deaminase inhibitor.
Falcon MG; Jones BR
J Gen Virol; 1977 Jul; 36(1):199-202. PubMed ID: 196039
[TBL] [Abstract][Full Text] [Related]
13. Topical butylated hydroxytoluene treatment of genital herpes simplex virus infections of guinea pigs.
Richards JT; Katz ME; Kern ER
Antiviral Res; 1985 Oct; 5(5):281-90. PubMed ID: 2998276
[TBL] [Abstract][Full Text] [Related]
14. Comparative activities of selected combinations of acyclovir, vidarabine, arabinosyl hypoxanthine, interferon, and polyriboinosinic acid-polyribocytidylic acid complex against herpes simplex virus type 2 in tissue culture and intravaginally inoculated mice.
Crane LR; Milne DA; Sunstrum JC; Lerner AM
Antimicrob Agents Chemother; 1984 Oct; 26(4):557-62. PubMed ID: 6083754
[TBL] [Abstract][Full Text] [Related]
15. Latent herpes simplex virus infections in sensory ganglia of mice after topical treatment with adenine arabinoside and adenine arabinoside monophosphate.
Klein RJ; Friedman-Kien AE
Antimicrob Agents Chemother; 1977 Nov; 12(5):577-81. PubMed ID: 200172
[TBL] [Abstract][Full Text] [Related]
16. Genital Herpesvirus homonis infection in mice. II. Treatment with phosphonoacetic acid, adenine arabinoside, and adenine arabinoside 5'-monophosphate.
Kern ER; Richards JT; Overall JC; Glasgow LA
J Infect Dis; 1977 Apr; 135(4):557-67. PubMed ID: 192805
[TBL] [Abstract][Full Text] [Related]
17. Topical SMIP-7.7, a toll-like receptor 7 agonist, protects against genital herpes simplex virus type-2 disease in the guinea pig model of genital herpes.
Bernstein DI; Cardin RD; Bravo FJ; Earwood J; Clark JR; Li Y; Mishra P; Li C; Nayak BP; Miller AT; Wu TY; Cooke MP; Valiante NM
Antivir Chem Chemother; 2014 Apr; 23(5):189-96. PubMed ID: 23232327
[TBL] [Abstract][Full Text] [Related]
18. Anti-herpes activity of adenine arabinoside monophosphate.
Trobe JD; Centifanto Y; Zam ZS; Varnell E; Kaufman HE
Invest Ophthalmol; 1976 Mar; 15(3):196-9. PubMed ID: 1254407
[TBL] [Abstract][Full Text] [Related]
19. Use of immunostimulatory sequence-containing oligonucleotides as topical therapy for genital herpes simplex virus type 2 infection.
Pyles RB; Higgins D; Chalk C; Zalar A; Eiden J; Brown C; Van Nest G; Stanberry LR
J Virol; 2002 Nov; 76(22):11387-96. PubMed ID: 12388699
[TBL] [Abstract][Full Text] [Related]
20. Effect of undecylenic acid as a topical microbicide against genital herpes infection in mice and guinea pigs.
Bourne N; Ireland J; Stanberry LR; Bernstein DI
Antiviral Res; 1999 Jan; 40(3):139-44. PubMed ID: 10027648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
